Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome.

Anti-Inflammatory Agents / pharmacology Humans Infant, Newborn Lung / drug effects Meconium Aspiration Syndrome / drug therapy Phospholipases A2 / drug effects Phospholipids / metabolism Pulmonary Surfactants / metabolism Surface-Active Agents / pharmacology
lung aeration meconium aspiration syndrome neonatal acute respiratory distress syndrome pulmonary surfactant surfactant proteins

Journal

American journal of respiratory cell and molecular biology
ISSN: 1535-4989
Titre abrégé: Am J Respir Cell Mol Biol
Pays: United States
ID NLM: 8917225

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 30 4 2020
medline: 21 10 2020
entrez: 30 4 2020
Statut: ppublish

Résumé

No

Identifiants

DOI: 10.1165/rcmb.2019-0413OC PMID: 32348683
pubmed: 32348683
doi: 10.1165/rcmb.2019-0413OC
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Phospholipids 0
Pulmonary Surfactants 0
Surface-Active Agents 0
Phospholipases A2 EC 3.1.1.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-337

Auteurs

Chiara Autilio (C)

Department of Biochemistry and Molecular Biology and Research Institute "Hospital 12 de Octubre (imas12)", Complutense University, Madrid, Spain.
ORCID: 0000-0003-3446-1692

Mercedes Echaide (M)

Department of Biochemistry and Molecular Biology and Research Institute "Hospital 12 de Octubre (imas12)", Complutense University, Madrid, Spain.

Shivani Shankar-Aguilera (S)

Division of Pediatrics and Neonatal Critical Care, A. Béclère Medical Center, Paris Saclay University Hospitals, APHP, Paris, France.

Rafael Bragado (R)

Research Institute "Instituto de Investigación Sanitaria-Fundación Jiménez Díaz (IIS FJD)", Madrid, Spain.

Davide Amidani (D)

Pharmacology and Toxicology Department Preclinical R&D, Chiesi Farmaceutici, Parma, Italy; and.

Fabrizio Salomone (F)

Pharmacology and Toxicology Department Preclinical R&D, Chiesi Farmaceutici, Parma, Italy; and.

Jesús Pérez-Gil (J)

Department of Biochemistry and Molecular Biology and Research Institute "Hospital 12 de Octubre (imas12)", Complutense University, Madrid, Spain.
ORCID: 0000-0003-3587-7147

Daniele De Luca (D)

Division of Pediatrics and Neonatal Critical Care, A. Béclère Medical Center, Paris Saclay University Hospitals, APHP, Paris, France.
Physiopathology and Therapeutic Innovation Unit, INSERM U999, Paris-Saclay University, Paris, France.
ORCID: 0000-0002-3846-4834

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-inflammatoires › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Appareil respiratoire › Poumon › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies néonatales › Syndrome d'aspiration méconiale › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Esterases › Carboxylic ester hydrolases › Phospholipases A › Phospholipases A2 › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Lipides › Lipides membranaires › Phospholipides › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents de l'appareil respiratoire › Surfactants pulmonaires › Surfactant Injury in the Early Phase of Severe...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Tensioactifs › Surfactant Injury in the Early Phase of Severe...